HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience by Dellanna F, Goldsmith D, Krendyukov A, Seidl A, Höbel N, Combe C

Get full text

Patients' preferences in periodontal disease treatment elicited alongside an IQWiG benefit assessment: a feasibility study by Vennedey V, Derman SHM, Hiligsmann M, Civello D, Schwalm A, Seidl A, Scheibler F, Stock S, Noack MJ, Danner M

Get full text

SEARCH FOR HEAVY NEUTRAL LEPTONS IN E+E- ANNIHILATIONS AT 29 GEV by Errede, D, Akerlof, C, Chapman, J, Harnew, N, Kesten, P, Kooijman, S, Meyer, D, Nitz, D, Rubin, D, Seidl, A, Thun, R, Trinko, T, Willutzky, M, Derrick, M, Fernandez, E, Fries, R, Hyman, L, Kooijman, P, Loos, J, Musgrave, B, Price, L, Schlereth, J, Sugano, K, Weiss, J, Wood, D

A novel carcinoembryonic antigen t cell bispecific antibody (cea tcb) for the treatment of solid tumors by Bacac, M, Fauti, T, Sam, J, Colombetti, S, Weinzierl, T, Ouaret, D, Bodmer, W, Lehmann, S, Hofer, T, Hosse, R, Moessner, E, Ast, O, Bruenker, P, Grau-Richards, S, Schaller, T, Seidl, A, Gerdes, C, Perro, M, Nicolini, V, Steinhoff, N, Dudal, S, Neumann, S, von Hirschheydt, T, Jaeger, C, Saro, J, Karanikas, V, Klein, C, Umana, P

COMPARISON OF LIGHT QUARK AND CHARM QUARK FRAGMENTATION by Kesten, P, Akerlof, C, Bonvicini, G, Chapman, J, Errede, D, Harnew, N, Meyer, D, Nitz, D, Seidl, A, Thun, R, Trinko, T, Willutzky, M, Derrick, M, Kooijman, P, Loos, J, Musgrave, B, Price, L, Schlereth, J, Sugano, K, Weiss, J, Wood, D, Baringer, P, Blockus, D, Brabson, B, Gray, S

EXPERIMENTAL LIMITS ON MONOJET PRODUCTION IN E+E- ANNIHILATION AT 29 GEV by Akerlof, C, Bonvicini, G, Chapman, J, Errede, D, Harnew, N, Kesten, P, Kooijman, S, Meyer, D, Nitz, D, Rubin, D, Seidl, A, Thun, R, Trinko, T, Willutzky, M, Derrick, M, Fernandez, E, Fries, R, Hyman, L, Kooijman, P, Loos, J, Musgrave, B, Price, L, Schlereth, J, Sugano, K, Weiss, J